Cormorant Asset Management Doesn’t Think Corbus Pharmaceuticals Holdings Inc. (CRBP) Is Done Soaring Just Yet

Page 6 of 8 – SEC Filing
Item 1.
(a)
Name of Issuer
Corbus Pharmaceuticals Holdings, Inc.
(b)
Address of Issuer’s Principal Executive Offices
100 River Ridge Dr.
Norwood, MA 02062
Item 2.
(a)
Name of Person Filing
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC
Cormorant Asset Management, LLC
Bihua Chen
(b)
Address of Principal Business Office or, if none, Residence
200 Clarendon Street, 52nd Floor
Boston, MA 02116
(c)
Citizenship
Cormorant Global Healthcare Master Fund, LP – Cayman Islands
Cormorant Global Healthcare GP, LLC – Delaware
Cormorant Asset Management, LLC – Delaware
Bihua Chen – United States
(d)
Title of Class of Securities
Common Stock
(e)
CUSIP Number
21833P103

Follow Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)